文献速递临床生化临床免疫

绝经后女性维生素D与K状态与骨密度关系研究

Vitamin D and vitamin K status in postmenopausal women with normal and low bone mineral density.
PubMed 文献 · Clin Chem Lab Med · 2024-01-01

该研究用LC-MS/MS测定131例绝经后女性多种维生素D和K代谢物,按双能X线吸收法分为骨密度正常组(68例)和低下组(63例)。结果显示两组间所有维生素代谢物水平相当,维生素状态充足与否其骨密度和骨小梁评分也无差异;仅维生素D代谢物与甲状旁腺激素呈负相关。

要点

  • 骨密度正常与低下组间维生素D和K代谢物水平无差异。
  • 维生素状态充足与否不影响骨密度和骨小梁评分。
  • 仅维生素D代谢物与甲状旁腺激素呈负相关。

核心结论

  • 绝经后女性维生素D和K状态与骨密度及骨小梁质量无关。
  • 仅观察到维生素D代谢物与甲状旁腺激素呈负相关。
  • 未观察到维生素D与K之间的协同效应。

研究设计与样本

  • 研究纳入131例绝经后女性,采用液相色谱串联质谱(LC-MS/MS)测定血清维生素代谢物。
  • 用双能X线吸收法区分骨密度正常(T值>-1,68例)与低下(T值<-1,63例)者。

主要发现

  • 平均年龄58.2±8.5岁。
  • 25(OH)D和总维生素K中位数(四分位距)分别为53.5(39.6-65.9)nmol/L和1.33(0.99-2.39)nmol/L。
  • 骨密度正常与低下组间所有维生素代谢物水平相当。
  • 维生素状态充足与不充足者骨密度和骨小梁评分相当。
  • 甲状旁腺激素与25(OH)D、24,25(OH)2D及维生素D代谢物比值呈负相关,而PINP和CTX-I无此相关。

关键数值与推荐

  • 维生素状态不充足的判定标准为至少满足一项:25(OH)D<50 nmol/L、24,25(OH)2D<3 nmol/L、维生素D代谢物比值<4%、总维生素K<0.91 nmol/L。

临床怎么用

  • 在此绝经后女性队列中,维生素D和K状态未显示与骨密度相关,评估骨健康时应结合其他因素。
  • 甲状旁腺激素与维生素D代谢物的负相关提示维生素D状态可能影响甲状旁腺激素水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Vitamin D and K are believed to promote bone health, but existing evidence is controversial. This study aimed to measure several metabolites of both vitamins by liquid chromatography tandem mass spectrometry (LC-MS/MS) in a cohort of postmenopausal women with low and normal bone mineral density (BMD). METHODS: Vitamin metabolites (25-hydroxyvitamin D (25[OH]D), 24,25-dihydroxyvitamin D (24,25(OH)2D), phylloquinone (K1), menaquinone-4 (MK-4) and MK-7) were measured in 131 serum samples by LC-MS/MS. The vitamin D metabolite ratio (VMR) was calculated. Parathyroid hormone (PTH), type I procollagen-N-terminal-peptide (PINP) and C-terminal telopeptides of type I collagen (CTX-I) were measured by immunoassay. Dual X-ray absorptiometry was performed to identify participants with normal (T-score>-1) and low (T-score<-1) BMD. RESULTS: Mean age was 58.2±8.5 years. BMD was normal in 68 and low in 63 women. Median (interquartile range) for 25(OH)D and total vitamin K concentrations were 53.5 (39.6-65.9) nmol/L and 1.33 (0.99-2.39) nmol/L. All vitamin metabolites were comparable in individuals with normal and low BMD. Furthermore, BMD and trabecular bone score were comparable in participants with adequate and inadequate vitamin status (at least one criterion was met: 25(OH)D <50 nmol/L, 24,25(OH)2D <3 nmol/L, VMR <4 %, total vitamin K <0.91 nmol/L). PTH, but not PINP or CTX-I, was inversely correlated with 25(OH)D, 24,25(OH)2D and VMR. Synergistic effects between vitamin D and K were not observed. CONCLUSIONS: Vitamin D and K status is not related to BMD and trabecular bone quality in postmenopausal women. Inverse associations were only seen between vitamin D metabolites and PTH.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Zelzer S, Meinitzer A, Enko D, et al. Vitamin D and vitamin K status in postmenopausal women with normal and low bone mineral density. Clin Chem Lab Med. 2024. PMID: 38158723. doi:10.1515/cclm-2023-1443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。